Pfizer Joins China’s Health Ministry To Bend Curve Of Soaring Chronic Diseases
This article was originally published in PharmAsia News
Executive Summary
Combining patient screening, physician training, hospital treatment and home care, Pfizer and China’s Ministry of Health aim to combat a rising curve of chronic diseases. For the company, a new focus on preventative drug use could boost sales.